FlashFeed

Lenacapavir injection twice a year could curb HIV – if it reaches those at risk

Lenacapavir, administered as just two injections per year, marks a major step forward over the daily pill currently used to prevent HIV infection. However, its long-term impact on reducing infections hinges on whether it can reliably reach the highest-risk populations. Distribution and accessibility remain the critical hurdles to overcome.